PHENYL N-HYDROXYCARBAMATE, 95%, 250mg

2-(4-Isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-ol, 95.0%, 1g

2-Bromo-5-hydroxy-benzaldehyde, 97.0%, 25g

Rebastinib, 99.91%, 10mg

tert-Butyl ((S)-2-(3,5-difluorophenyl)-1-((S)-oxiran-2-yl)ethyl)carbamate, 95.0%, 2g

Ethyl 2-(2-hydroxyphenyl)acetate, 95.0%, 1g

(1-Methylazetidin-3-yl)methanamine, 95.0%, 1g

4-(Isopropylsulfonyl)benzoic acid, 95.0%, 1g

2-Chlorooxazolo[5,4-b]pyridine, 95.0%, 250mg

Oxyde de molybdène(VI), min 99,8 %, pa, 50 g, emballage plastique.

3-Ethynylaniline hydrochloride, 95.0%, 25g

Benzylidenehydrazine, 95%, 250mg

Ethyl 4-methyl-1H-pyrazole-5-carboxylate, 95.0%, 1g